FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2549912159> ?p ?o ?g. }

• W2549912159 abstract "Abstract Abstract 3483 In aplastic anemia (AA), the marrow is not “empty” but replaced by fat; the increase in adipocytes number and size is most obvious on three dimensional reconstructions of the marrow in human and murine (Takaku T, Blood. 2008). A reciprocal relationship exists between adipogenesis and osteogenesis, and osteoblasts constitute the hematopoietic niche and play an active role in the regulation of stem cells and progenitors. Fat in the marrow has been considered an epiphenomenon in AA. However, a recent report suggested that bone marrow (BM) adipocytes negatively regulated hematopoiesis in mouse models (Naveiras O, Nature. 2009). Peroxisome proliferator-activated receptor-g (PPAR-g) is a key transcription factor for adipogenesis, and blocking PPAR-g signaling inhibited adipogenesis in vitro (Wright HM, J Biol Chem. 2000). To examine the role of BM adipocytes, we investigated the effects of PPAR-g antagonists, bisphenol A diglycidyl ether (BADGE, 30 mg/kg/day) and GW9662 (1 mg/kg/day), on hematopoiesis in a mouse model of immune-mediated BM failure (Chen J, J Immunol. 2007). We induced BM failure by infusion of lymph node (LN) cells from C57BL/6 mice into sublethally irradiated C.B10-H2(b)/LilMcd (C.B10) recipient mice that were matched at major histocompatibility antigens but differed in multiple minor histocompatibility antigens. In adaptation of the “runt” disease model, mice uniformly develop progressive and fatal pancytopenia, closely resembling human BM failure, without other evidence of graft-versus-host disease. We treated recipient mice with BADGE, GW9662, or control vehicle from day -1 to day 14. On day 14, mice were sacrificed and evaluated by peripheral blood (PB) cell counting and BM cellularity, as well as morphology of marrow adipocytes. Mice in the BADGE- and GW9662-treated groups showed higher numbers of leukocytes, neutrophils, and platelets in PB and higher total nucleated cells and Lin- Sca1+ c-kit+ stem cells in BM than did animals in the control group. Both confocal microscopic imaging and hematoxylin and eosin staining of BM also showed significantly higher numbers of nucleated cells and many fewer and smaller adipocytes in the treated groups (Figure 1). We also investigated dose response of BADGE in the treatment of AA mice. Low dose of BADGE (15 mg/kg/day) had no effect while high dose of BADGE (60 mg/kg/day) seemed to have no extra benefit for the BM hematopoiesis compared with the medium dose (30 mg/kg/day). However, we also noted in PPAR-g antagonist-treated groups that there was significantly less CD8+ T cell infiltration of BM, as determined by flow cytometry. We speculated that PPAR- g antagonists might also negatively affect activation of cytotoxic T cells. By magnetic beads-based multiplex assay, we found the concentrations of inflammation-related cytokines in the plasma, including Interleukin-6, tumor necrosis factor alpha, monocyte chemotactic protein-1 were markedly decreased in PPAR- g antagonist-treated groups. When we performed PCR arrays focusing on adipogenesis and inflammasome pathways, we found that expression of adipogenesis genes was greatly decreased in the treated groups, including Agt (−149 folds), Cebpa (−4.7 folds), Acacb (−11.7 folds), Fabp4 (−3.2 folds), Adig (−14.2 folds), and Bmp2 (−12.9 folds). The expression of inflammation- or inflammasome-related genes including Nlrc4 (−11.3 folds), Mapk12 (−4.8 folds), Ptgs2 (−8.7 folds), and Rela (−5.9 folds) was also decreased while apoptosis inhibitor genes including Xiap (+17.5 folds), Mapk1 (+6.6 folds), and Bcl2l1 (+3.9 folds) were increased in the treated groups. In vitro, BADGE and GW9662 inhibited activation and proliferation of T cells stimulated with anti-CD3/CD28 or phorbol myristate acetate/ionomycin. These data suggested that BADGE and GW9662 inhibition was not specific for adipogenesis but affected T cell activation. Indeed, PPAR-g antagonists failed to ameliorate pancytopenia and BM hypoplasia in the mice exposed to either a lethal or sublethal dose of total body irradiation. PPAR-g antagonists may act to attenuate murine immune mediated marrow failure by mechanism of inhibition of T-cell activation. Figure 1. Histology of femurs from untreated bone marrow failure mice and PPAR-g antagonists treated mice. Both BADGE and GW9662 inhibited adipogenesis and increased cellularity in the bone marrow of AA mice. Figure 1. Histology of femurs from untreated bone marrow failure mice and PPAR-g antagonists treated mice. Both BADGE and GW9662 inhibited adipogenesis and increased cellularity in the bone marrow of AA mice. Disclosures: No relevant conflicts of interest to declare." @default.
• W2549912159 created "2016-11-30" @default.
• W2549912159 creator A5004581558 @default.
• W2549912159 creator A5025683999 @default.
• W2549912159 creator A5036551462 @default.
• W2549912159 creator A5050700780 @default.
• W2549912159 creator A5061349997 @default.
• W2549912159 creator A5072063614 @default.
• W2549912159 creator A5075319144 @default.
• W2549912159 creator A5089194366 @default.
• W2549912159 date "2012-11-16" @default.
• W2549912159 modified "2023-09-28" @default.
• W2549912159 title "Adipocytes and Aplastic Anemia: Peroxisome Proliferator-Activated Receptor-γ (PPAR- γ) Antagonists Attenuate Bone Marrow Failure in an Aplastic Anemia Mouse Model but Not in Radiation Marrow Destruction" @default.
• W2549912159 doi "https://doi.org/10.1182/blood.v120.21.3483.3483" @default.
• W2549912159 hasPublicationYear "2012" @default.
• W2549912159 type Work @default.
• W2549912159 sameAs 2549912159 @default.
• W2549912159 citedByCount "0" @default.
• W2549912159 crossrefType "journal-article" @default.
• W2549912159 hasAuthorship W2549912159A5004581558 @default.
• W2549912159 hasAuthorship W2549912159A5025683999 @default.
• W2549912159 hasAuthorship W2549912159A5036551462 @default.
• W2549912159 hasAuthorship W2549912159A5050700780 @default.
• W2549912159 hasAuthorship W2549912159A5061349997 @default.
• W2549912159 hasAuthorship W2549912159A5072063614 @default.
• W2549912159 hasAuthorship W2549912159A5075319144 @default.
• W2549912159 hasAuthorship W2549912159A5089194366 @default.
• W2549912159 hasConcept C109159458 @default.
• W2549912159 hasConcept C122927707 @default.
• W2549912159 hasConcept C126322002 @default.
• W2549912159 hasConcept C134018914 @default.
• W2549912159 hasConcept C171089720 @default.
• W2549912159 hasConcept C203014093 @default.
• W2549912159 hasConcept C2780007613 @default.
• W2549912159 hasConcept C2780525284 @default.
• W2549912159 hasConcept C2781440808 @default.
• W2549912159 hasConcept C28328180 @default.
• W2549912159 hasConcept C502942594 @default.
• W2549912159 hasConcept C71924100 @default.
• W2549912159 hasConcept C86803240 @default.
• W2549912159 hasConcept C95444343 @default.
• W2549912159 hasConceptScore W2549912159C109159458 @default.
• W2549912159 hasConceptScore W2549912159C122927707 @default.
• W2549912159 hasConceptScore W2549912159C126322002 @default.
• W2549912159 hasConceptScore W2549912159C134018914 @default.
• W2549912159 hasConceptScore W2549912159C171089720 @default.
• W2549912159 hasConceptScore W2549912159C203014093 @default.
• W2549912159 hasConceptScore W2549912159C2780007613 @default.
• W2549912159 hasConceptScore W2549912159C2780525284 @default.
• W2549912159 hasConceptScore W2549912159C2781440808 @default.
• W2549912159 hasConceptScore W2549912159C28328180 @default.
• W2549912159 hasConceptScore W2549912159C502942594 @default.
• W2549912159 hasConceptScore W2549912159C71924100 @default.
• W2549912159 hasConceptScore W2549912159C86803240 @default.
• W2549912159 hasConceptScore W2549912159C95444343 @default.
• W2549912159 hasLocation W25499121591 @default.
• W2549912159 hasOpenAccess W2549912159 @default.
• W2549912159 hasPrimaryLocation W25499121591 @default.
• W2549912159 hasRelatedWork W1994902609 @default.
• W2549912159 hasRelatedWork W2022734786 @default.
• W2549912159 hasRelatedWork W2075530237 @default.
• W2549912159 hasRelatedWork W2168200596 @default.
• W2549912159 hasRelatedWork W2288152801 @default.
• W2549912159 hasRelatedWork W2377779559 @default.
• W2549912159 hasRelatedWork W2513104818 @default.
• W2549912159 hasRelatedWork W2551607461 @default.
• W2549912159 hasRelatedWork W2557015384 @default.
• W2549912159 hasRelatedWork W2562773902 @default.
• W2549912159 hasRelatedWork W2566943937 @default.
• W2549912159 hasRelatedWork W2699355749 @default.
• W2549912159 hasRelatedWork W2753345484 @default.
• W2549912159 hasRelatedWork W2776118590 @default.
• W2549912159 hasRelatedWork W2897117401 @default.
• W2549912159 hasRelatedWork W2921881647 @default.
• W2549912159 hasRelatedWork W2969578606 @default.
• W2549912159 hasRelatedWork W2986662505 @default.
• W2549912159 hasRelatedWork W3036704986 @default.
• W2549912159 hasRelatedWork W307334176 @default.
• W2549912159 isParatext "false" @default.
• W2549912159 isRetracted "false" @default.
• W2549912159 magId "2549912159" @default.
• W2549912159 workType "article" @default.